This Sources Sought opportunity from Department Of Veterans Affairs was posted on July 8, 2024. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

6550--Bio-Rad Quality Control Distributor to include Lot number standardization and Lot Sequester for VISN 16

Closed

36C25624Q1112Federal

Submission Closed07/19/2024, 06:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325413

New

DIBBS

TEST KIT, CORONAVIRUS D

Solicitation # SPE2DS-27-T-1071

Solicitation SPE2DS-27-T-1071, issued by the DLA Troop Support Medical Supply Chain, is for the procurement of one case of Abbott BinaxNOW COVID-19 Antigen self-test kits for over-the-counter, at-home use. Each case contains 12 kits with 2 tests per kit. The items must be stored between 2-30 degrees Celsius and have a non-extendable shelf life of 12 months, with no more than one month elapsed from the date of manufacture to the date of delivery. Delivery is required within 20 days after receipt of the order, with a final delivery date of October 30, 2026, to the USS IDAHO (SSN 799). The contract mandates strict adherence to Medical Marking Standard No. 1, which supersedes MIL-STD-129, and requires labels to include the contract or lot number and the date of manufacture, expiration, or retest. Packaging must be commercial, utilizing sealed unit containers and suitable exterior shipping containers. Inspection and acceptance will occur at the destination per FAR 52.246-2. Administrative requirements include the use of the Wide Area Workflow system for electronic invoicing and compliance with various FAR and DFARS clauses regarding cybersecurity, the Buy American Act, and the prohibition of covered defense telecommunications equipment. Quotations are due by November 3, 2026.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

CULTURE MEDIUM, THAYER-

Solicitation # SPE2DS-27-T-1066

Solicitation SPE2DS-27-T-1066 is a request for quotations issued by the DLA Troop Support Medical Supply Chain for the procurement of one package of Thayer-Martin Modified (MTM II) Agar culture medium, identified by NSN 6550-01-711-1542. This dark brown, ready-to-use plated medium is specifically designed for the isolation of pathogenic Neisseria from specimens containing mixed flora of bacteria and fungi. The product is delivered in packages of 100 plates and requires strict refrigeration storage between 2 to 8 degrees Celsius (36 to 46 degrees Fahrenheit) and must not be frozen. The contract mandates a non-extendable shelf life of three months, with a requirement that no more than 14 days elapse between the date of manufacture and the date of delivery to the government. Delivery is set for JBER, Alaska, with a required delivery date of October 27, 2026, under FOB Destination terms. Packaging must be commercial and sealed to prevent damage, with marking adhering to Medical Marking Standard No. 1 and shelf-life labels following MMS1C. Administrative requirements include electronic invoicing via the Wide Area WorkFlow system and compliance with various FAR and DFARS clauses, including the Buy American Act, Berry Amendment, and safeguarding of covered defense information. Evaluation will consider technical data for any alternate products offered and may include HUBZone price evaluation preferences. Inspection and acceptance will occur at the destination.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Supply of ALBAcyte Blood Bank ReagentsThis subcontract involves the manufacture and supply of specialized ALBAcyte blood bank reagents for prime contractors supporting the Department of Veterans Affairs North Texas Health Care System. The scope of work includes the delivery of A1, A2, B, IgG Sensitized, Antibody ID Panels, and C3 Coated RBCs. To ensure product efficacy, the contractor must utilize shipping containers that maintain reagent integrity and adhere to a defined Quality Plan and FDA approval standards. Deliveries are to be made FOB Destination to the Transfusion Medicine Unit located in Dallas, Texas. The contract is categorized under NAICS code 325413 and is managed through the Department of Veterans Affairs Network Contract Office 17.

257-NETWORK Contract Office 17 (36C257)

POSTED

DEADLINE

6550--Blood Bank Reagents

Solicitation # 36C25727Q0065

The Department of Veterans Affairs VA North Texas Health Care System is issuing a Sources Sought Notice to identify qualified vendors capable of providing blood bank reagents for the Transfusion Medicine Unit in Dallas, Texas. These reagents, including ALBAcyte A1, A2, B, IgG Sensitized, Antibody ID Panels, and C3 Coated Red Blood Cells, are essential for manual blood typing and serum antibody detection used in cross-matching blood for transfusions. The anticipated acquisition strategy includes a base year starting May 1, 2027, with four subsequent one-year option periods extending through April 30, 2032. To be considered, vendors must be FDA approved, provide documentation of such approval, and maintain a defined quality plan with adequate supply availability. All shipments must be FOB Destination, and the contractor is responsible for providing appropriate shipping containers. Interested vendors must submit an electronic capability statement in PDF or Word format, including the place of manufacture for all listed reagents, to the designated contract specialist by November 5, 2026, at 9:00 AM CST. This notice is for market research purposes only to determine the appropriate acquisition strategy, such as a small business set-aside, and does not constitute a formal solicitation.

257-NETWORK Contract Office 17 (36C257)

POSTED

DEADLINE

6505--DRESSING, DRAWTEX 4IN X 4IN (VA-27-00014447)

Solicitation # 36C77027Q0015

The Department of Veterans Affairs, National CMOP Office, is conducting market research through a Sources Sought announcement to identify qualified sources for the procurement of Drawtex Dressing, 4in X 4in, packaged as 10ct per box. This action is for market research purposes only and is not a formal solicitation for quotes; therefore, no contract will be awarded based on this specific announcement. The place of performance is located in Ladson, South Carolina, and the primary point of contact is Contract Specialist Claudine Challinor. Interested respondents must submit their information via email by November 3, 2026. Required details include the company's SAM Unique ID Number, business size (Small, Large, SDVOSB, or VOSB), and point of contact information. Specifically, the government is seeking to determine if the respondent is the manufacturer, the manufacturer's product number, and the place of manufacturing. If the respondent is not the manufacturer, they must provide a letter of authorization from the original equipment manufacturer or provide detailed product literature and specifications for alternative products that demonstrate similarities to the Drawtex hydro conductive wound dressing.

National Cmop Office (36C770)

POSTED

DEADLINE

6550--Optilite analyzer reagents

Solicitation # 36C26227Q0052

The Department of Veterans Affairs, Southern Arizona Healthcare System, is soliciting a Firm-Fixed Price Blanket Purchase Agreement under solicitation 36C26227Q0052 for the procurement of FDA-approved reference testing reagents and consumables validated for use on the Optilite analyzer. The scope includes specific items such as Freelite Kappa, Freelite Lambda, and Ceruloplasmin reagents, as well as TENCELL cuvettes and sample cups. To ensure system performance and safety, all materials must be manufactured by Binding Site Laboratories, and substitutions are prohibited. The contract is issued as a full and open competition under NAICS code 325413, with a total estimated period of performance of sixty months, consisting of a base period from November 9, 2026, to November 8, 2027, followed by four one-year option periods. The award will be granted to the responsible offeror whose proposal is most advantageous to the government, based on a technical acceptability review of the Statement of Work and the lowest price. Deliveries are required to be made to various VA Medical Centers across Arizona, California, and New Mexico, with standard orders delivered within four working days of placement. All shipments must be destination-based, with the vendor assuming all shipping costs and adhering to strict packaging standards to prevent damage. Invoicing is handled electronically through the Department of Veterans Affairs Financial Services Center in accordance with the Prompt Payment Act. Quotes must be submitted via email to Contract Specialist Carlos Magana by November 4, 2026.

262-NETWORK Contract Office 22 (36C262)

POSTED

DEADLINE

Supply of i-STAT PT Plus Control Reagent Level 1This subcontract involves the procurement and delivery of i-STAT PT Plus Control Reagent Level 1 for coagulation testing to support prime contractors fulfilling Department of Defense supply contracts. The scope of work requires the delivery of two boxes, each containing ten 1.0 mL units, shipped FOB Destination to a performance location in APO 96260-5479. To ensure quality and safety, all supplied reagents must adhere to Regulation 864.7750 Class II requirements and maintain full compliance with Registration, Listing, Labeling, and Good Manufacturing Practices. This requirement is managed under NAICS code 325413 for the Medical Supply Chain MD Surg FSF agency.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

CONTROL SET, BLOOD CHEM

Solicitation # SPE2DS-27-T-0906

Solicitation SPE2DS-27-T-0906 is a request for quotations from DLA Troop Support for two sets of DXH 500 Series Blood Chemistry Control (NSN 6550-01-688-9090). This assayed whole blood control is used to monitor multi-parameter hematology cell counters and includes abnormal low, normal, and abnormal high components. The items must be stored refrigerated and upright between 2 to 8 degrees Celsius and protected from freezing and overheating. Delivery is required within 20 days after receipt of order, with a required delivery date of October 27, 2026, under FOB Destination terms. The contract imposes strict shelf-life requirements, specifying a non-extendable shelf life of 3 months, with no more than 13 days elapsed from the date of manufacture to the date of delivery. Packaging must be commercial and compliant with RP001 and MIL-STD-2073-1E, while marking must adhere to Medical Marking Standard No. 1. Invoicing is to be processed electronically via the Wide Area Workflow system. This is not a small business set-aside, and the procurement falls under NAICS code 325413. Compliance with the Buy American and Balance of Payments Program and DFARS safeguarding of covered defense information is required.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

CONTROL, BLOOD CHEMISTR

Solicitation # SPE2DS-27-T-0950

Solicitation SPE2DS-27-T-0950 is a Request for Quotations issued by the Department of Defense, DLA Troop Support Medical Supply Chain, for the procurement of two boxes of i-STAT PT Plus Control Reagent Level 1 (NSN 6550-01-728-5703). This reagent is used for coagulation testing and is compatible with the i-STAT PT Plus cartridge and the i-STAT 1 Government Field Kit analyzer. Each box contains ten 1.0 mL units. The required delivery date is October 23, 2026, with a delivery window of 83 days after award. Inspection and acceptance will occur at the destination per FAR 52.246-2. The contract mandates strict quality and storage requirements, including refrigeration between 2 to 8 degrees Celsius and a non-extendable shelf life of 12 months. Items must be delivered within one month of the manufacture date. Packaging must be commercial and adhere to MIL-STD-2073-1E and RP001, with marking compliant with Medical Marking Standard No. 1. Labels must include the contract/lot number and manufacture or expiration dates. The procurement is not a small business set-aside, though a HUBZone price evaluation preference may be applied. Compliance with the Buy American Act and DFARS domestic material restrictions is required, and electronic invoicing must be processed through the Wide Area WorkFlow system.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

BPA - Consumable Supplies for Terumo Trima Accel Blood Collection systems

Solicitation # HT942627QE003

The Defense Health Agency is soliciting quotations to establish a Blanket Purchase Agreement (BPA) for the recurring resupply of consumable products for three Terumo Trima Accel Blood Collection Systems used by the USAISR Combat Casualty Care Research Team 1 in Texas. To maintain FDA approval and satisfy research protocols, the contractor must provide original manufacturer-supplied consumables, including Teruflex 500ml collection bags, Trima Platelet Kits, Isoplate Solution (PAS-F), TSCD Wafers, ACD-A Solution, and 150 mL couplers. This procurement is a 100 percent set-aside for Service-Disabled Veteran-Owned Small Businesses under NAICS 325413. The resulting BPA will have a 60-month ordering period with a total ceiling of 35 million dollars, though some documentation notes a lower limit of 350,000 dollars. Individual call orders are capped at 50,000 dollars, while Government Purchase Card orders are limited to 15,000 dollars. Awards will be made on a Lowest Price Technically Acceptable basis, with technical capability rated as pass or fail. All payment requests and receiving reports must be processed electronically through the Wide Area WorkFlow system. Quotations are due by November 6, 2026, and must be submitted in two separate volumes covering technical capability and pricing.

Army Medical Resources Acq Activity

POSTED

DEADLINE

Custom ArcherDX VariantPlex NGS Target-Enrichment KitsThis subcontract involves the supply of custom-designed Next-Generation Sequencing target-enrichment library preparation kits to support prime contractors on NIH NHLBI projects. The required kits must be manufactured using proprietary ArcherDX VariantPlex Anchored Multiplex PCR chemistry and pre-amplification ligation of unique molecular barcodes. To ensure operational compatibility, all delivered kits must function with Archer Analysis software and Illumina NovaSeq instruments. Managed under the National Institutes of Health Olao within the Department of Health and Human Services, the contract falls under NAICS code 325413. The procurement process began with a posting date of October 22, 2026, and established a response deadline of November 2, 2026.

National Institutes Of Health Olao

POSTED

DEADLINE

6550--VISN Cepheid GeneXpert Testing Supplies Base Plus 3 Op Yr RFQ

Solicitation # 36C24527Q0042

The Department of Veterans Affairs, specifically the VA North Atlantic Health Network (HSA 1.3), is soliciting a firm-fixed-price, Indefinite Delivery/Indefinite Quantity (IDIQ) contract for Cepheid GeneXpert testing supplies. This requirement covers the procurement of FDA-approved reagents, consumables, and service for PCR analyzers to detect various pathogens, including CoV-2, Influenza, RSV, MRSA, and Mycobacterium Tuberculosis. The contract is structured with a base period ending October 31, 2027, and three subsequent one-year option periods extending through October 31, 2030. Deliveries will be made to multiple VA Medical Centers across Maryland, West Virginia, and Washington DC. This acquisition is set aside for HUBZone small businesses. Award will be determined using the Lowest Price Technically Acceptable (LPTA) method, evaluating technical acceptability, delivery performance, past performance, and price, with additional credit given to certified SDVOSB or VOSB offerors. Key contractor requirements include being an authorized distributor, acknowledging orders within 24 hours, and guaranteeing a minimum four-month expiration date on reagents. Additionally, the vendor must provide an emergency plan to deliver replacement supplies within 24 hours if products are found to be defective. Invoices must be submitted electronically, and payments will be processed in accordance with the Prompt Payment Act.

245-NETWORK Contract Office 5 (36C245)

POSTED

7 days ago

DEADLINE

in 7 days

General Info

Agency

Department Of Veterans Affairs → 256-NETWORK Contract Office 16 (36C256)

NAICS

325413 - In-Vitro Diagnostic Substance Manufacturing

Place of Performance

Set-Aside

NONE

Documents

VISN 16 Bio-Rad Controls Lab Info and Estimated Usage

specifications

High

Bio-Rad Quality Control Distributor for VISN 16

6 pages · sources-sought

Low

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseClosed

PostedJul 8

Sources Sought

Response DeadlineJul 19

Deadline has passed

Submission Closed

07/19/2024, 06:00:00 PM UTC

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Veterans Affairs → 256-NETWORK Contract Office 16 (36C256)

Contacts1 person available

OfficeRIDGELAND, MS, 39157, USA

Organization / AgencyDepartment Of Veterans Affairs → 256-NETWORK Contract Office 16 (36C256)

Office AddressRIDGELAND, MS, 39157, USA

Contacts

Tammie ChaneyContracting Officer

contact@example.gov

+1 (555) 000-0000

Full Description

THIS IS A SOURCES SOUGHT (MARKET SURVEY) NOTICE ONLY, NOT A SOLICITATION ANNOUNCEMENT AND SHOULD NOT BE CONSIDERED AS SUCH. The Department of Veterans Affairs, South Central VA Health Care System (VISN 16) has a requirement for an authorized distributor of Bio-Rad® products to provide Bio-Rad ® Quality Control (QC) material to include VISN wide lot number standardization, lot sequester, and management for VISN 16 Medical Centers and Outpatient Clinic Laboratories. The intent of the projected RFQ is for the award of a firm-fixed price BPA (Blanket Purchase Agreement) for a base year (October 1, 2024 through September 30, 2025) plus 4 one-year options. VISN 16 locations are identified in Attachment A. The Government will not pay for any information received in response to this notice, nor will the Government compensate any respondent for any cost incurred in developing the information provided to the Government. This notice does not constitute a commitment by the Government. Any information provided in response to this market survey will be used for informational purposes only and will not be released. Vendor participation is not a promise of future business with the Government. The purpose of this notice is to conduct market research and obtain information from qualified businesses. Potential sources shall submit: Business name, address, point of contact and phone number Business size, any applicable socio-economic category, SAMS UEI and DUNS number Information for recent/relevant projects equivalent in nature/size and complexity along with contract number(s), Capability statement and product literature demonstrating ability to meet all of the requirements listed Identification of company s GSA/Federal Supply Schedules (Group 65 VII) Valid Vendor authorization letter of distribution for the required Bio-Rad Quality Control products signed by the manufacturer The NAICS Code for this procurement is 325413, small business size standard is 1,250 employees. Potential sources must demonstrate experience and knowledge of required products and capability to provide products and services. Requirements: The Contractor shall be responsible for assuring that an adequate supply of Bio-Rad quality control materials is available to meet the requirements. All participating V16 laboratories will be on the same lot of Bio-Rad control material at the same time. These items will be of the highest quality, sensitivity, specificity and tested to assure precision and accuracy. Following BPA award, unexpected changes in product will be at the expense of the contractor. Potential sources shall also demonstrate in their response their abilities related to the following: Contractor shall have a valid, signed Vendor authorization letter for distribution of the required Bio-Rad Quality Control products from the manufacturer. Contractor shall provide Bio-Rad quality control materials, assayed and unassayed as delineated for each Bio-Rad product number and product name in Attachment A as described in their respective package inserts and listed in manufacturer s catalog. Bio-Rad control materials shall include all analytes under the provided Bio-Rad product number and product name. Assayed control products with accompanying instrument specific ranges and target values shall be available for existing V16 chemistry/immunochemistry testing instrumentation. Dedicated/designated staff assigned to manage the VISN 16 accounts ensuring BPA requirements are met. Contractor shall assign a single individual to manage the VISN 16 standardized lot sequesters. The individual shall serve as the main point of contact for all communications regarding control products, inventories and sequestered products. Individual shall be experienced in managing multi-facility standardized sequesters of equivalent size and scope. A second individual or team will be identified to serve as the back-up point of contact when the primary assigned individual is unavailable. Contractor shall establish and sequester specific lots of the required Bio-Rad controls to ensure all ordering locations are using the same lot of controls at the same time for like products. Contractor shall establish sequesters based on each respective laboratory test menu and workload in consideration of specific Bio-Rad control product stability, control frequency, lot expiration and availability of storage capacity within each lab at the required conditions. Contractor shall offer maximized expiration dates for control lots to reduce frequency of new lot validations and/or parallel cross over studies for each laboratory. Duration of each lot sequester shall also be maximized by the Contractor to reduce the number and frequency of lot changes and parallel studies for each laboratory. Contractor shall appropriately and effectively manage inventories to prevent product waste. Contractor may relocate product quantities within the network laboratories to enhance standardization of lot numbers at a given time. Concurrence shall be obtained from impacted laboratories prior to any adjustments. Adjustments shall not significantly reduce lot dating or create additional expense to the Government. Contractor shall furnish monthly sequestered inventory updates by laboratory. Contractor shall notify respective laboratories of removals/reductions of lot sequesters prior to monthly updates when significant changes occur and when sequestered quantities reach zero (0). Contractor shall supply courtesy samples of upcoming lot of each control to sites prior to expiration or depletion of sequester inventory for performance of lot validations and/or parallel cross over studies. Shipment timing shall allow for completion of appropriate studies to meet accreditation requirements in adherence to individual lab policy/procedure. Contractor shall provide recall notification, regardless of level, to each facility, and to the VISN 16 COR. Medical Centers shall be notified immediately of any backorder item(s). Contractor s failure to provide any item, contained herein within the specified delivery time shall allow a Medical Center to obtain the product from another source. Deliveries of BPA items shall be made the next business day (Tu-Fri) when orders are placed Monday -Thursday by the specified daily cut-off hour. Deliveries shall be within regular work hours, which are usually 8:00 AM to 4:30 PM Central Time, Monday through Friday, for Medical Center Laboratories. Deliveries to Outpatient Clinic Laboratories shall be made during their hours of operation but no later than 30 minutes prior to daily close of business. Note: Hours may vary at different laboratories. Required Bio-Rad Control Products: Bio-Rad Item Number Product Name 149 BIO-RAD CARDIAC MARKER LT LOW PLUS 1 LIQUID 182 BIO-RAD CARDIAC MARKER PLUS LEVEL 2 LIQUID 183 BIO-RAD CARDIAC MARKER PLUS LEVEL 3 LIQUID 361 BIO-RAD LIQUICHEK IA PLUS LEVEL 1 362 BIO-RAD LIQUICHEK IA PLUS LEVEL 2 363 BIO-RAD LIQUICHEK IA PLUS LEVEL 3 364 BIO-RAD SPECIALTY IA LIQUID LEVEL 1 365 BIO-RAD SPECIALTY IA LIQUID LEVEL 2 366 BIO-RAD SPECIALTY IA LIQUID LEVEL 3 383 BIO-RAD LIQUICHEK Serum Volatile LEVEL 1 384 BIO-RAD LIQUICHEK Serum Volatile LEVEL 2 397 BIO-RAD LIQUICHEK URINE CHEM LEVEL 1 398 BIO-RAD LIQUICHEK URINE CHEM LEVEL 2 423 BIO-RAD URINE TOX S1E LOW OP LIQUID 424 BIO-RAD URINE TOX S2E LOW OPLIQUID 460 BIO-RAD URINE TOX NEGATIVE LIQUID 514 BIO-RAD LIQUICHEK SED RATE LEVEL 1 515 BIO-RAD LIQUICHEK SED RATE LEVEL 2 544 BIO-RAD LIQUICHEK ETH/AMM LEVEL 1 545 BIO-RAD LIQUICHEK ETH/AMM LEVEL 2 546 BIO-RAD LIQUICHEK ETH/AMM LEVEL 3 547 BIO-RAD TUMOR MARKER, Level 1 LIQUID 549 BIO-RAD TUMOR MARKER, Level 3 LIQUID 594 BIO-RAD LIQUICHEK IMMUNOLOGY LEVEL 1 596 BIO-RAD LIQUICHEK IMMUNOLOGY LEVEL 3 683 BIO-RAD S1O LOW OPIATE 697 BIO-RAD MULTIQUAL UNASSAYED LEVEL 1 LIQUID 699 BIO-RAD MULTIQUAL UNASSAYED LEVEL 3 LIQUID 751 BIO-RAD LIQUICHEK SPINE FLUID LEVEL 1 752 BIO-RAD LIQUICHEK SPINE FLUID LEVEL 2 12001084 BIO-RAD Liquichek Cardiac Troponin Control Level 1 - 12006239 BIO-RAD Liquichek Cardiac Troponin Control Level 2 12006369 BIO-RAD Liquichek Cardiac Troponin Control Level 3 27124 BIO-RAD Lyphochek Specialty IA Level 1 27125 BIO-RAD Lyphochek Specialty IA Level 2 27126 BIO-RAD Lyphochek Specialty IA Level 3 12011343 BIO-RAD DIABETES Level 1 LIQUID 12011345 BIO-RAD DIABETES Level 3 LIQUID 12000404 BIO-RAD LIQUICHEK Whole Blood Immunosuppressant Level 1 12000405 BIO-RAD LIQUICHEK Whole Blood Immunosuppressant Level 2 12000406 BIO-RAD LIQUICHEK Whole Blood Immunosuppressant Level 3 12000407 BIO-RAD LIQUICHEK Whole Blood Immunosuppressant Level 4 12005787 BIO-RAD LIQUICHEK OPIATE CONTROL Level 2 12012693 BIO-RAD Liquichek Serum Indices Level Hemolysis 12012694 BIO-RAD Liquichek Serum Indices Level Icterus 12012695 BIO-RAD Liquichek Serum Indices Level Lipemia 12012696 BIO-RAD Liquichek Serum Indices Level Non-Interfered A list of required Bio-Rad control products by product number and annual estimated usage by laboratory are provided in Attachment A. Potential sources are to respond by email only to the Contracting Officer, Tammie Chaney at contact@example.gov no later than 1:00pm CST on July 19, 2024. Include the following in the email subject line: RFI - Bio-Rad QC Products . Questions or inquiries will not be answered or acknowledged, and no feedback will be provided. No vendor will be provided information on solicitations issued on a Government Point of Entry based on this sources sought notice. This notice is to assist in determining sources only. There is no solicitation currently available. There is no guarantee, expressed or implicit, that the market research for this acquisition will result in a particular set-aside, sole source award or any other guarantee of award strategy. All information is to be provided on a voluntary basis and at no charge to the Government. DISCLAIMER: This notice is issued solely for informational and planning purposes and does not constitute a solicitation. Responses to this notice are not offers and cannot be accepted by the Department of Veterans Affairs to form a binding contract. Respondents are solely responsible for all expenses associated with responding to this notice.